Cuts at AstraZeneca | GenomeWeb

Cuts at AstraZeneca

AstraZeneca has announced that it is cutting about 1,600 jobs over three years, the Wall Street Journal reports. The Nature News blog adds that about 1,300 of those jobs are in research and development. The company will also be moving its headquarters from London to Cambridge in the UK.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Nucleic Acids Research this week: tool to discover copy number variants, single-nucleus RNA sequencing study of myoblasts, and more.

A study of Tasmanian devil genomes suggests they are evolving resistance to devil facial tumor disease.

Theranos has withdrawn its request for emergency clearance of a Zika virus blood test, according to the Wall Street Journal.

An assistant professor who was fired from Mount Sinai School of Medicine has allegedly shot the school's dean, the New York Times reports.